In this work, matrix SPRi biosensors are used as a new analytical method to examine the levels of selected proteins (HIF-1α, ANG-2, and IL-1β) in plasma and tissue homogenates from patients with diagnosed brain glioma. This evidence concerns the gene ANGPT2 and brain glioma.